BIONICHE LIFE SCIENCES INC. - Announcements

Currently unlisted. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BNC	Removal from Official List at COB 03/02/2014		03/02/14	27.04KB	Share
BNC	Suspension from Official Quotation cob 28/01/2014	PRICE SENSITIVE	28/01/14	80.2KB	Share
BNC	Change of Director's Interest Notice		22/01/14	111.89KB	Share
BNC	AMENDED Appendix 3B		13/01/14	123.89KB	Share
BNC	Bioniche Life Sciences Appoints New Chief Operating Officer		08/01/14	32.9KB	Share
BNC	Appendix 3B		08/01/14	120.45KB	Share
BNC	CDI Holder De-listing Package		23/12/13	209.88KB	Share
BNC	Bioniche Life Sciences Inc. Delisting Approved by the ASX		12/12/13	204.74KB	Share
BNC	Appendix 3B		10/12/13	120.49KB	Share
BNC	Illness Related to E. coli O157 Costs $403.9 in Canada		05/12/13	72.31KB	Share
BNC	Bioniche Announces its Intention to Delist from the ASX	PRICE SENSITIVE	02/12/13	31.64KB	Share
BNC	Bioniche Horse Product Approved for Sale in the U.S.	PRICE SENSITIVE	02/12/13	71.55KB	Share
BNC	Change of Director's Interest Notice		19/11/13	73.03KB	Share
BNC	Material Change Report	PRICE SENSITIVE	15/11/13	70.04KB	Share
BNC	Initial Director's Interest Notice		11/11/13	36.16KB	Share
BNC	Final Director's Interest Notice		11/11/13	96.44KB	Share
BNC	Summary of Material Terms of Employment Contract with CEO		08/11/13	33.87KB	Share
BNC	Appendix 3B		08/11/13	118.66KB	Share
BNC	2013 Annual General Meeting Voting Results		08/11/13	15.12KB	Share
BNC	Q1 F2014 MD&A, Financials & Certificates		07/11/13	354.39KB	Share
BNC	Bioniche Reports Fiscal 2014 Fiscal Q1 Results	PRICE SENSITIVE	06/11/13	78.37KB	Share
BNC	AGM Presentation		06/11/13	623.28KB	Share
BNC	Bioniche Life Sciences Announces New CEO	PRICE SENSITIVE	05/11/13	33.99KB	Share
BNC	Bioniche 2013 Proxy Circular Available		21/10/13	33.22KB	Share
BNC	Bioniche Provides Update on Plans for New Drug Submission	PRICE SENSITIVE	08/10/13	41.25KB	Share
BNC	Notice of Annual & Special Meeting/Proxy Form		04/10/13	440.54KB	Share
BNC	Appendix 3B		04/10/13	126.96KB	Share
BNC	Annual Report to shareholders		04/10/13	2.16MB	Share
BNC	Change of Director's Interest Notices		03/10/13	233.19KB	Share
BNC	F2013 Annual Information Form		01/10/13	1.61MB	Share
BNC	Fiscal 2013 MD&A and Audited Financial Statements		01/10/13	853.12KB	Share
BNC	Bioniche Reports Fiscal 2013 Year-End Results	PRICE SENSITIVE	30/09/13	229.62KB	Share
BNC	Change of Director's Interest Notice		30/09/13	111.69KB	Share
BNC	Warrant Indenture		27/09/13	376.03KB	Share
BNC	Change of Director's Interest Notice		27/09/13	72.34KB	Share
BNC	Bioniche Closes Equity Offering and Private Placement		27/09/13	65.86KB	Share
BNC	Bioniche Files Final Prospectus for Canadian Equity Offering		20/09/13	218.92KB	Share
BNC	Short Form Prospectus	PRICE SENSITIVE	19/09/13	426.04KB	Share
BNC	Amended Material Change Report		19/09/13	40.12KB	Share
BNC	Initial Director's Interest Notice		17/09/13	16.95KB	Share
BNC	Disclosure Document		13/09/13	127.52KB	Share
BNC	Material Change Report		12/09/13	38.24KB	Share
BNC	Bioniche CEO Announces his New Role with the Company	PRICE SENSITIVE	12/09/13	67.13KB	Share
BNC	Bioniche and Concerned Shareholders Announce a Settlement	PRICE SENSITIVE	12/09/13	69.41KB	Share
BNC	Change of Director's Interest Notice		09/09/13	75.7KB	Share
BNC	Appendix 3B		09/09/13	119.28KB	Share
BNC	Material Change Report		19/08/13	243.42KB	Share
BNC	Change of Director's Interest Notice		09/08/13	75.78KB	Share
BNC	Appendix 3B		09/08/13	121.62KB	Share
BNC	Preliminary Short Form Prospectus for Canadian Offering	PRICE SENSITIVE	08/08/13	470.57KB	Share
BNC	Bioniche Confirms Pricing of Canadian Equity Offering	PRICE SENSITIVE	08/08/13	67.05KB	Share
BNC	Trading Halt	PRICE SENSITIVE	07/08/13	111.35KB	Share
BNC	Licence Agreement		07/08/13	212.82KB	Share
BNC	Amended and Restated Loan Agreement with Paladin Labs		07/08/13	914.6KB	Share
BNC	Bioniche Files Prospectus for Canadian Equity Offering	PRICE SENSITIVE	07/08/13	72.49KB	Share
BNC	Ontario Court Confirms Timing of Bioniches AGM		24/07/13	64.43KB	Share
BNC	Bioniche's Folltropin Gains Access To Additional Markets	PRICE SENSITIVE	16/07/13	64.78KB	Share
BNC	AMENDED Appendix 3B		12/07/13	128.7KB	Share
BNC	Change of Director's Interest Notices		11/07/13	188.42KB	Share
BNC	Health Canada Provides Direction to Bioniche Re Urocidin	PRICE SENSITIVE	09/07/13	40.84KB	Share
BNC	Appendix 3B		08/07/13	119.08KB	Share
BNC	Bioniche deal closes with Paladin	PRICE SENSITIVE	08/07/13	47.67KB	Share
BNC	Appendix 3B		05/07/13	112.12KB	Share
BNC	Change of Director's Interest Notice		05/07/13	75.72KB	Share
BNC	Dissident Shareholder Notice of Meeting		03/07/13	1.07MB	Share
BNC	Bioniche Responds to Dissident Shareholders Latest Tactics		01/07/13	66.21KB	Share
BNC	Bioniche VMC Validation Update		28/06/13	64.58KB	Share
BNC	Change of Director's Interest Notice		26/06/13	71.89KB	Share
BNC	Shareholder Newsletter		26/06/13	6.83MB	Share
BNC	Amended and Restated Revenue Interest Agreement		17/06/13	2.54MB	Share
BNC	Bioniche Founder and CEO Addresses Shareholders		13/06/13	76.2KB	Share
BNC	Material Document - Disclosure Document		13/06/13	50.52KB	Share
BNC	Material Change Report - Disclosure Document		13/06/13	58.87KB	Share
BNC	Appendix 3B		06/06/13	112.18KB	Share
BNC	Change of Director's Interest Notice		06/06/13	75.87KB	Share
BNC	Paladin Labs and Bioniche Life Sciences Sign Deals	PRICE SENSITIVE	06/06/13	48.58KB	Share
BNC	Bioniche Responds to Shareholders and Rejects Early Meeting		30/05/13	64.82KB	Share
BNC	Change of Director's Interest Notices		24/05/13	188.73KB	Share
BNC	Becoming a substantial holder - Release date amended		20/05/13	30.32KB	Share
BNC	AMENDED Appendix 3B		17/05/13	113.31KB	Share
BNC	Bioniche Engages Evercore Partners	PRICE SENSITIVE	14/05/13	67.23KB	Share
BNC	F2013 Q3 Letter to Shareholders, MD&A, Financials & Certific		10/05/13	382.35KB	Share
BNC	Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results	PRICE SENSITIVE	09/05/13	135.45KB	Share
BNC	Bioniche Responds to Request for Shareholder Meeting		06/05/13	65.2KB	Share
BNC	Appendix 3B		06/05/13	111.52KB	Share
BNC	Change of Director's Interest Notice		06/05/13	75.82KB	Share
BNC	Bioniche Acknowledges Request for Shareholder Meeting		29/04/13	62.02KB	Share
BNC	Bioniche Responds to Letter from Former Biovail Executives		23/04/13	64.54KB	Share
BNC	Bioniche Experiences Increased Trading Activity		22/04/13	63.29KB	Share
BNC	Bioniche E. coli O157 Vaccine to be Used In Study in Sweden	PRICE SENSITIVE	19/04/13	71.29KB	Share
BNC	Bioniche receive Gov't Support for 2nd Gen. E. Coli Vaccine	PRICE SENSITIVE	28/03/13	70.24KB	Share
BNC	Bioniche Reacts to Canadian Federal Budget	PRICE SENSITIVE	27/03/13	34.41KB	Share
BNC	Bioniche Life Sciences Reorganizes One of its Business Units	PRICE SENSITIVE	08/03/13	254.37KB	Share
BNC	Appendix 3B		05/03/13	112.23KB	Share
BNC	Vaccination of Cattle Reduces Public Health Risk of E. coli		01/03/13	73.24KB	Share
BNC	Change of Director's Interest Notice		28/02/13	75.84KB	Share
BNC	Appendix 3B		25/02/13	119.95KB	Share
BNC	Letter to Shareholders, MDA, Financial Statements & Certific		11/02/13	387.04KB	Share
BNC	Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results	PRICE SENSITIVE	07/02/13	130.48KB	Share
BNC	Change of Director's Interest Notice		07/02/13	76.07KB	Share

BNCRemoval from Official List at COB 03/02/2014
03/02/14		27.04KB	Share
BNCSuspension from Official Quotation cob 28/01/2014
28/01/14	PRICE SENSITIVE	80.2KB	Share
BNCChange of Director's Interest Notice
22/01/14		111.89KB	Share
BNCAMENDED Appendix 3B
13/01/14		123.89KB	Share
BNCBioniche Life Sciences Appoints New Chief Operating Officer
08/01/14		32.9KB	Share
BNCAppendix 3B
08/01/14		120.45KB	Share
BNCCDI Holder De-listing Package
23/12/13		209.88KB	Share
BNCBioniche Life Sciences Inc. Delisting Approved by the ASX
12/12/13		204.74KB	Share
BNCAppendix 3B
10/12/13		120.49KB	Share
BNCIllness Related to E. coli O157 Costs $403.9 in Canada
05/12/13		72.31KB	Share
BNCBioniche Announces its Intention to Delist from the ASX
02/12/13	PRICE SENSITIVE	31.64KB	Share
BNCBioniche Horse Product Approved for Sale in the U.S.
02/12/13	PRICE SENSITIVE	71.55KB	Share
BNCChange of Director's Interest Notice
19/11/13		73.03KB	Share
BNCMaterial Change Report
15/11/13	PRICE SENSITIVE	70.04KB	Share
BNCInitial Director's Interest Notice
11/11/13		36.16KB	Share
BNCFinal Director's Interest Notice
11/11/13		96.44KB	Share
BNCSummary of Material Terms of Employment Contract with CEO
08/11/13		33.87KB	Share
BNCAppendix 3B
08/11/13		118.66KB	Share
BNC2013 Annual General Meeting Voting Results
08/11/13		15.12KB	Share
BNCQ1 F2014 MD&A, Financials & Certificates
07/11/13		354.39KB	Share
BNCBioniche Reports Fiscal 2014 Fiscal Q1 Results
06/11/13	PRICE SENSITIVE	78.37KB	Share
BNCAGM Presentation
06/11/13		623.28KB	Share
BNCBioniche Life Sciences Announces New CEO
05/11/13	PRICE SENSITIVE	33.99KB	Share
BNCBioniche 2013 Proxy Circular Available
21/10/13		33.22KB	Share
BNCBioniche Provides Update on Plans for New Drug Submission
08/10/13	PRICE SENSITIVE	41.25KB	Share
BNCNotice of Annual & Special Meeting/Proxy Form
04/10/13		440.54KB	Share
BNCAppendix 3B
04/10/13		126.96KB	Share
BNCAnnual Report to shareholders
04/10/13		2.16MB	Share
BNCChange of Director's Interest Notices
03/10/13		233.19KB	Share
BNCF2013 Annual Information Form
01/10/13		1.61MB	Share
BNCFiscal 2013 MD&A and Audited Financial Statements
01/10/13		853.12KB	Share
BNCBioniche Reports Fiscal 2013 Year-End Results
30/09/13	PRICE SENSITIVE	229.62KB	Share
BNCChange of Director's Interest Notice
30/09/13		111.69KB	Share
BNCWarrant Indenture
27/09/13		376.03KB	Share
BNCChange of Director's Interest Notice
27/09/13		72.34KB	Share
BNCBioniche Closes Equity Offering and Private Placement
27/09/13		65.86KB	Share
BNCBioniche Files Final Prospectus for Canadian Equity Offering
20/09/13		218.92KB	Share
BNCShort Form Prospectus
19/09/13	PRICE SENSITIVE	426.04KB	Share
BNCAmended Material Change Report
19/09/13		40.12KB	Share
BNCInitial Director's Interest Notice
17/09/13		16.95KB	Share
BNCDisclosure Document
13/09/13		127.52KB	Share
BNCMaterial Change Report
12/09/13		38.24KB	Share
BNCBioniche CEO Announces his New Role with the Company
12/09/13	PRICE SENSITIVE	67.13KB	Share
BNCBioniche and Concerned Shareholders Announce a Settlement
12/09/13	PRICE SENSITIVE	69.41KB	Share
BNCChange of Director's Interest Notice
09/09/13		75.7KB	Share
BNCAppendix 3B
09/09/13		119.28KB	Share
BNCMaterial Change Report
19/08/13		243.42KB	Share
BNCChange of Director's Interest Notice
09/08/13		75.78KB	Share
BNCAppendix 3B
09/08/13		121.62KB	Share
BNCPreliminary Short Form Prospectus for Canadian Offering
08/08/13	PRICE SENSITIVE	470.57KB	Share
BNCBioniche Confirms Pricing of Canadian Equity Offering
08/08/13	PRICE SENSITIVE	67.05KB	Share
BNCTrading Halt
07/08/13	PRICE SENSITIVE	111.35KB	Share
BNCLicence Agreement
07/08/13		212.82KB	Share
BNCAmended and Restated Loan Agreement with Paladin Labs
07/08/13		914.6KB	Share
BNCBioniche Files Prospectus for Canadian Equity Offering
07/08/13	PRICE SENSITIVE	72.49KB	Share
BNCOntario Court Confirms Timing of Bioniches AGM
24/07/13		64.43KB	Share
BNCBioniche's Folltropin Gains Access To Additional Markets
16/07/13	PRICE SENSITIVE	64.78KB	Share
BNCAMENDED Appendix 3B
12/07/13		128.7KB	Share
BNCChange of Director's Interest Notices
11/07/13		188.42KB	Share
BNCHealth Canada Provides Direction to Bioniche Re Urocidin
09/07/13	PRICE SENSITIVE	40.84KB	Share
BNCAppendix 3B
08/07/13		119.08KB	Share
BNCBioniche deal closes with Paladin
08/07/13	PRICE SENSITIVE	47.67KB	Share
BNCAppendix 3B
05/07/13		112.12KB	Share
BNCChange of Director's Interest Notice
05/07/13		75.72KB	Share
BNCDissident Shareholder Notice of Meeting
03/07/13		1.07MB	Share
BNCBioniche Responds to Dissident Shareholders Latest Tactics
01/07/13		66.21KB	Share
BNCBioniche VMC Validation Update
28/06/13		64.58KB	Share
BNCChange of Director's Interest Notice
26/06/13		71.89KB	Share
BNCShareholder Newsletter
26/06/13		6.83MB	Share
BNCAmended and Restated Revenue Interest Agreement
17/06/13		2.54MB	Share
BNCBioniche Founder and CEO Addresses Shareholders
13/06/13		76.2KB	Share
BNCMaterial Document - Disclosure Document
13/06/13		50.52KB	Share
BNCMaterial Change Report - Disclosure Document
13/06/13		58.87KB	Share
BNCAppendix 3B
06/06/13		112.18KB	Share
BNCChange of Director's Interest Notice
06/06/13		75.87KB	Share
BNCPaladin Labs and Bioniche Life Sciences Sign Deals
06/06/13	PRICE SENSITIVE	48.58KB	Share
BNCBioniche Responds to Shareholders and Rejects Early Meeting
30/05/13		64.82KB	Share
BNCChange of Director's Interest Notices
24/05/13		188.73KB	Share
BNCBecoming a substantial holder - Release date amended
20/05/13		30.32KB	Share
BNCAMENDED Appendix 3B
17/05/13		113.31KB	Share
BNCBioniche Engages Evercore Partners
14/05/13	PRICE SENSITIVE	67.23KB	Share
BNCF2013 Q3 Letter to Shareholders, MD&A, Financials & Certific
10/05/13		382.35KB	Share
BNCBioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results
09/05/13	PRICE SENSITIVE	135.45KB	Share
BNCBioniche Responds to Request for Shareholder Meeting
06/05/13		65.2KB	Share
BNCAppendix 3B
06/05/13		111.52KB	Share
BNCChange of Director's Interest Notice
06/05/13		75.82KB	Share
BNCBioniche Acknowledges Request for Shareholder Meeting
29/04/13		62.02KB	Share
BNCBioniche Responds to Letter from Former Biovail Executives
23/04/13		64.54KB	Share
BNCBioniche Experiences Increased Trading Activity
22/04/13		63.29KB	Share
BNCBioniche E. coli O157 Vaccine to be Used In Study in Sweden
19/04/13	PRICE SENSITIVE	71.29KB	Share
BNCBioniche receive Gov't Support for 2nd Gen. E. Coli Vaccine
28/03/13	PRICE SENSITIVE	70.24KB	Share
BNCBioniche Reacts to Canadian Federal Budget
27/03/13	PRICE SENSITIVE	34.41KB	Share
BNCBioniche Life Sciences Reorganizes One of its Business Units
08/03/13	PRICE SENSITIVE	254.37KB	Share
BNCAppendix 3B
05/03/13		112.23KB	Share
BNCVaccination of Cattle Reduces Public Health Risk of E. coli
01/03/13		73.24KB	Share
BNCChange of Director's Interest Notice
28/02/13		75.84KB	Share
BNCAppendix 3B
25/02/13		119.95KB	Share
BNCLetter to Shareholders, MDA, Financial Statements & Certific
11/02/13		387.04KB	Share
BNCBioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results
07/02/13	PRICE SENSITIVE	130.48KB	Share
BNCChange of Director's Interest Notice
07/02/13		76.07KB	Share

REFRESH

1 2

BIONICHE LIFE SCIENCES INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available